Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli
<p>Abstract</p> <p>Background</p> <p>Cisplatin has been in use for 40 years for treatment of germ line and other forms of cancer. Oxaliplatin is approved for treatment of metastatic colorectal cancer. Thirty to forty percent of cancer patients receiving these agents dev...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2009-02-01
|
| Series: | Molecular Pain |
| Online Access: | http://www.molecularpain.com/content/5/1/9 |